Published in Eur J Nucl Med on May 01, 1996
Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer (1983) 1.73
Grey scale echography in the diagnosis of intrahepatic disease. J Clin Ultrasound (1973) 1.71
Ultrasound and scintigraphy in the differential diagnosis of obstructive jaundice. J Clin Ultrasound (1974) 1.70
FDG accumulation and tumor biology. Nucl Med Biol (1998) 1.59
The potential of intratumoural unsealed radioactive source therapy. Eur J Nucl Med (2001) 1.49
Future directions for unsealed source radionuclide therapy for bone metastases. Eur J Nucl Med Mol Imaging (2002) 1.45
Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42
31P-NMR studies of a human tumour in situ. Lancet (1983) 1.27
Measurements of human breast cancer using magnetic resonance spectroscopy: a review of clinical measurements and a report of localized 31P measurements of response to treatment. NMR Biomed (1998) 1.27
In-vivo 31P magnetic resonance spectroscopy for monitoring treatment response in breast cancer. Lancet (1989) 1.18
Clinical radioisotope scanning. Br J Radiol (1967) 1.16
Gray scale ultrasound imaging. The anatomy and pathology of the liver. Radiology (1976) 1.15
Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet (1983) 1.12
False positive 131I whole body scans in thyroid cancer. Br J Radiol (2000) 1.11
Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol (1984) 1.10
Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology (1996) 1.09
A co-ordinate transfer system for the Pho Gamma 3 Nuclear Chicago gamma camera. Br J Radiol (1969) 1.09
Iodine kinetic studies during amiodarone treatment. J Clin Endocrinol Metab (1986) 1.03
The prognostic significance of the half-life of serum CA 125 in patients responding to chemotherapy for epithelial ovarian carcinoma. Br J Obstet Gynaecol (1989) 1.01
Combined pancreas and liver scanning using a double isotope technique. Br J Radiol (1971) 0.98
Radiation dose assessment in radioiodine therapy. 2. Practical implementation using quantitative scanning and PET, with initial results on thyroid carcinoma. Radiother Oncol (1989) 0.98
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. Br J Cancer (2002) 0.98
62Cu-PTSM and PET used for the assessment of angiotensin II-induced blood flow changes in patients with colorectal liver metastases. Eur J Nucl Med (2001) 0.96
A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism. Br J Cancer (1991) 0.95
Phospholipid metabolites, prognosis and proliferation in human breast carcinoma. NMR Biomed (1994) 0.94
A constant depth ultrasonic scanner. Br J Radiol (1971) 0.94
The role of ultrasound in the assessment and treatment of abdominal metastases from testicular tumours. Clin Radiol (1977) 0.94
The mechanism of accumulation of tumour-localising radiopharmaceuticals. Eur J Nucl Med (1998) 0.93
Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy. Lancet (1983) 0.92
The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma. Br J Cancer (1989) 0.91
Scintigraphic studies of space-occupying liver disease. Semin Nucl Med (1972) 0.91
Thyroid cancer: differentiated carcinoma. Cancer Treat Rev (1996) 0.91
The effects of single dose oral hydralazine on blood flow through human lung tumours. Radiother Oncol (1990) 0.91
99mTc-HMPAO as a tumour blood flow agent. Eur J Nucl Med (1987) 0.89
Tumour imaging radiopharmaceuticals. Br J Radiol (1975) 0.88
Three-dimensional display of data obtained by single photon emission computed tomography. Br J Radiol (1987) 0.88
Tests for liver metastases in breast cancer: evaluation of liver scan and liver ultrasound. Clin Oncol (1980) 0.88
Measurement of radiation dose to the thyroid using positron emission tomography. Br J Radiol (1987) 0.88
Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography. Eur J Nucl Med (1997) 0.87
Technetium-99m HMPAO and SPECT in the assessment of blood flow in human lung tumours. Br J Cancer (1989) 0.87
A clinical evaluation of grey-scale ultrasonography. Br J Radiol (1976) 0.87
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone. Eur J Nucl Med Mol Imaging (2006) 0.86
Clinical tests on a prototype semiconductor gamma-camera. Br J Radiol (1971) 0.85
A pulse generator for use with the Picker MagnaScanner colour printer. Br J Radiol (1967) 0.85
Dose-response study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy. Eur J Nucl Med (1994) 0.84
Radioimmunoscintigraphy of squamous carcinomas of the head and neck. Head Neck Surg (1987) 0.84
Focal areas of increased renal tracer uptake on bone scans can mimic metastases in the lower ribs. Br J Radiol (1996) 0.84
Spleen scanning. Proc R Soc Med (1969) 0.83
Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases. Br J Cancer (2001) 0.83
HM-PAO assessment of human tumour perfusion. Eur J Cancer Clin Oncol (1987) 0.83
Low-dose 131I in treatment of Graves' disease. J R Soc Med (1985) 0.83
The use of 18-F for bone scanning. Br J Radiol (1967) 0.83
Thyroid cancer: a review of treatment and follow-up. Ann Nucl Med (1996) 0.82
A comparision of grey-scale ultrasound with other methods for the detection of liver metastases from breast carcinoma. Clin Oncol (1976) 0.81
Demonstration of blood flow patterns in human soft tissue sarcomas using 99mTc-labelled hexamethyl propyleneamineoxime. Br J Surg (1990) 0.79
99Tcm-labelled meso-HMPAO and glutathione content of human lung tumours. Nucl Med Commun (1989) 0.79
An evaluation of 99mTc-HMPAO uptake in cerebral gliomas--a comparison with X-ray CT. Eur J Nucl Med (1990) 0.79
Initial experience with Tc-99m-HM-PAO in the study of brain tumors. Eur J Nucl Med (1988) 0.79
Effects of cellular repair and proliferation on targeted radionuclide therapy: a modelling study. Phys Med Biol (2000) 0.78
The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine-labelled antibodies. Br J Radiol (1983) 0.78
The stability and distribution of Tc-HIDA in vivo and in vitro. Eur J Nucl Med (1979) 0.78
The effect of intra-tumour heterogeneity on the distribution of phosphorus-containing metabolites within human breast tumours: an in vitro study using 31P NMR spectroscopy. NMR Biomed (1991) 0.77
The effect of chelating agents on the distribution of monoclonal antibodies in mice. J Nucl Med (1986) 0.77
99Tcm-MDP blood-pool phase in the assessment of repetitive strain injury. Nucl Med Commun (1997) 0.77
Detection of increased blood flow to the affected arm in repetitive strain injury with radionuclide and Doppler ultrasound studies. A case report. Clin Nucl Med (1995) 0.77
Cellular versus vascular rejection in transplant kidneys. Correlation of radionuclide and Doppler studies with histology. Nucl Med Commun (1993) 0.77
Proliferation is associated with 2-deoxy-D-[1-3H]glucose uptake by T47D breast tumour and SW480 and SW620 colonic tumour cells. Nucl Med Biol (1998) 0.77
A different approach to the use of unsealed radionuclides for cancer therapy. Eur J Nucl Med (1995) 0.77
Thyroid imaging using positron emission tomography--a comparison with ultrasound imaging and conventional scintigraphy in thyrotoxicosis. Br J Radiol (1990) 0.77
Uptake of technetium-99m hexamethylpropylene amine oxime labelled white cells in lymph nodes involved in non-Hodgkin's lymphoma. Eur J Nucl Med (1995) 0.77
Clinical isotope scanning using 67 Ga citrate in the management of Hodgkin's disease. Br J Radiol (1972) 0.76
Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management. Eur J Nucl Med (1995) 0.76
An antibody-desferrioxamine conjugate labelled with 67Ga. Int J Rad Appl Instrum B (1986) 0.76
An unusually high nasal uptake of radioactive iodine during treatment for carcinoma of the thyroid. Am J Roentgenol Radium Ther Nucl Med (1966) 0.76
Radiation dose assessments in radioiodine (131I) therapy. 1. The necessity for in vivo quantitation and dosimetry in the treatment of carcinoma of the thyroid. Radiother Oncol (1989) 0.76
2-Deoxy-D-[1-3H]glucose uptake by MCF7 and T47D breast tumour cells under conditions of active proliferation and serum deprivation. Anticancer Res (1998) 0.76
Radiation dose assessment in radioiodine therapy. Dose-response relationships in differentiated thyroid carcinoma using quantitative scanning and PET. Radiother Oncol (1993) 0.76
Value of protein-bound radioactive iodine measurements in the management of differentiated thyroid cancer treated with (131)I. Br J Radiol (2001) 0.75
Phosphocholine and choline content of rat sarcoma cells grown in the presence and absence of serum. Anticancer Res (1996) 0.75
Radionuclide therapy dose calculations: what accuracy can be achieved? Eur J Nucl Med (1997) 0.75
A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease. Eur J Cancer (1992) 0.75
The appearance of the pyramidal lobe on thyroid scintigraphy. Nucl Med Commun (1984) 0.75
Uptake of gallium-67 in colonic and rectal tumours. Br Med J (1972) 0.75
Value of gallium scanning in seminoma of the testis. Br Med J (1976) 0.75
Role of ultrasound in the management of ovarian carcinoma. J R Soc Med (1983) 0.75
Pancreas scanning using a double isotope technique. Proc R Soc Med (1971) 0.75
Diagnosis of liver metastases using ultrasound and isotope scanning techniques. J R Soc Med (1978) 0.75
Clinical applications of isotopes in diagnosis and research. Proc R Soc Med (1966) 0.75
Liver diseases and liver tumours from the diagnostic point of view. Radioisotope methods. Proc R Soc Med (1974) 0.75
The gamma camera in malignant disease. Proc R Soc Med (1972) 0.75
The use of 131I-MIBG in the imaging of metastatic carcinoid tumours. Br J Cancer (1988) 0.75
Low-dose radioiodine given six-monthly in Graves' disease. J R Soc Med (1985) 0.75
Comparison of radioisotope and ultrasound scans of the thyroid. Proc R Soc Med (1975) 0.75
Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigen. Br J Cancer (1993) 0.75
The uptake of gallium 67 in colonic macrophages. Eur J Nucl Med (1976) 0.75
Visualisation of mediastinal lymph nodes by scintillation scanning. Indian J Cancer (1967) 0.75
Ultrasound scanning. Nurs Mirror Midwives J (1977) 0.75
Accuracy of grey-scale ultrasonography of liver and spleen in Hodgkin's disease and the other lymphomas compared with isotope scans. Clin Radiol (1977) 0.75
Renal involvement with non-Hodgkin's lymphoma: investigation of a recent case. Br J Radiol (1978) 0.75